Table 3 Factors that may affect drug demand patterns during COVID-19 in Yemen as perceived by the participants (N = 330)

1. Antibiotics

 Increased

95.6 (218)

94.3 (66)

96.0 (240)

92.5 (74)

 Unchanged

4.4 (10)

5.7 (4)

4.0 (10)

7.5 (6)

 P value

0.746*

0.232*

 Pearson Chi-square value

0.211

1.609

2. Antivirals

 Increased

25.9 (59)

35.7 (25)

30.8 (77)

25.0 (20)

 Unchanged

74.1 (169)

64.3 (45)

69.2 (173)

75.0 (60)

 P value

0.110*

0.526*

 Pearson Chi-square value

2.560

1.40

3. Antimalarials

 Increased

64.5 (147)

52.9 (37)

60.0 (150)

65.0 (52)

 Unchanged

35.8 (81)

47.1 (33)

40.0 (100)

35.0 (28)

 P value

0.08*

0.652^#

 Pearson Chi-square value

3.060

1.271

4. Anxiolytics and sedatives

 Increased

70.2 (160)

70.0 (49)

71.2 (178)

68.7 (55)

 Unchanged

29.8 (68)

30.0 (21)

28.8 (72)

31.3 (25)

 P value

0.978^#

0.675^#

 Pearson Chi-square value

0.001

0.175

5. Antithrombotic

 Increased

66.2 (151)

64.3 (45)

67.2 (168)

66.3 (53)

 Unchanged

33.8 (77)

35.7 (25)

32.8 (82)

33.7 (27)

 P value

0.764^#

0.875^#

 Pearson Chi-square value

0.090

0.025

6. Analgesics and antipyretics

 Increased

99.1 (226)

98.6 (69)

99.2 (248)

97.5 (78)

 Unchanged

0.9 (1)

1.4 (2)

0.8 (2)

2.5 (2)

 P value

0.554*

0.248*

 Pearson Chi-square value

0.163

1.463

7. Vitamins and supplements

 Increased

94.7 (216)

85.7 (60)

94.0 (235)

90.0 (72)

 Unchanged

5.3 (12)

14.3 (10)

6.0 (15)

10.0 (8)

 P value

0.012#

0.221#

 Pearson Chi-square value

6.376

1.496

8. Ondansetron with antimalarials or macrolides

 Increased

83.7 (169)

82.5 (52)

87.7 (192)

75.3 (55)

 Unchanged

16.3 (33)

17.5 (11)

12.3 (27)

24.7 (18)

 P value

0.924*

0.026#

 Pearson Chi-square value

12.787

7.310